Login
Signup
Kai Wirt
@Aktien2022
2Yr
I would still keep Novavax and possibly wait that the vlt bring out new vaccines, which can increase sales. I am also in the red with them...🥴
Show original (German)
Like
•
•
Answer
Leuchtturm
@Leuchtturm
2Yr
@Aktien2022
what does the company's information say about the development of new vaccines, so long the company is not to be seen as "growth potential"
Show original (German)
Like
•
•
Answer
Leuchtturm
@Leuchtturm
2Yr
@Aktien2022
because research is one thing - clinical trials and market approvals are another 🤔.
Show original (German)
Like
•
•
Answer
